• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助依赖型腺病毒载体

Helper-Dependent Adenoviral Vectors.

作者信息

Rosewell Amanda, Vetrini Francesco, Ng Philip

机构信息

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030 USA.

出版信息

J Genet Syndr Gene Ther. 2011 Oct 29;Suppl 5. doi: 10.4172/2157-7412.s5-001.

DOI:10.4172/2157-7412.s5-001
PMID:24533227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3923448/
Abstract

Helper-dependent adenoviral vectors are devoid of all viral coding sequences, possess a large cloning capacity, and can efficiently transduce a wide variety of cell types from various species independent of the cell cycle to mediate long-term transgene expression without chronic toxicity. These non-integrating vectors hold tremendous potential for a variety of gene transfer and gene therapy applications. Here, we review the production technologies, applications, obstacles to clinical translation and their potential resolutions, and the future challenges and unanswered questions regarding this promising gene transfer technology.

摘要

辅助依赖型腺病毒载体不含所有病毒编码序列,具有大容量克隆能力,能有效转导来自不同物种的多种细胞类型,且不依赖细胞周期,可介导长期转基因表达而无慢性毒性。这些非整合型载体在多种基因转移和基因治疗应用中具有巨大潜力。在此,我们综述了其生产技术、应用、临床转化的障碍及其潜在解决方案,以及关于这项有前景的基因转移技术的未来挑战和未解决的问题。

相似文献

1
Helper-Dependent Adenoviral Vectors.辅助依赖型腺病毒载体
J Genet Syndr Gene Ther. 2011 Oct 29;Suppl 5. doi: 10.4172/2157-7412.s5-001.
2
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.辅助依赖型腺病毒载体介导的基因治疗的挑战与前景
Biomedicines. 2014 Apr 2;2(2):132-148. doi: 10.3390/biomedicines2020132.
3
Helper-dependent adenoviral vectors for liver-directed gene therapy.辅助依赖性腺病毒载体用于肝脏定向基因治疗。
Hum Mol Genet. 2011 Apr 15;20(R1):R7-13. doi: 10.1093/hmg/ddr143. Epub 2011 Apr 5.
4
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.用辅助依赖型腺病毒载体进行基因治疗:大型动物模型研究的经验教训。
Virus Genes. 2017 Oct;53(5):684-691. doi: 10.1007/s11262-017-1471-x. Epub 2017 Jun 7.
5
Advances in helper-dependent adenoviral vector research.辅助依赖型腺病毒载体研究进展
Curr Gene Ther. 2008 Aug;8(4):222-35. doi: 10.2174/156652308785160647.
6
Helper-dependent adenoviral vectors for gene therapy.用于基因治疗的辅助依赖型腺病毒载体。
Hum Gene Ther. 2005 Jan;16(1):1-16. doi: 10.1089/hum.2005.16.1.
7
Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.辅助依赖性腺病毒载体的基因治疗:当前进展与未来展望。
Viruses. 2010 Sep;2(9):1886-1917. doi: 10.3390/v2091886. Epub 2010 Sep 3.
8
Improved system for helper-dependent adenoviral vector production.用于辅助依赖型腺病毒载体生产的改进系统。
Mol Ther. 2003 Nov;8(5):846-52. doi: 10.1016/j.ymthe.2003.08.014.
9
Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.肝靶向基因治疗辅助依赖性腺病毒载体:现状与未来挑战。
Curr Pharm Des. 2011;17(24):2488-99. doi: 10.2174/138161211797247532.
10
Biosafety of adenoviral vectors.腺病毒载体的生物安全性。
Curr Gene Ther. 2003 Dec;3(6):527-43. doi: 10.2174/1566523034578140.

引用本文的文献

1
FastAd: A versatile toolkit for rapid generation of single adenoviruses or diverse adenoviral vector libraries.FastAd:一种用于快速生成单一腺病毒或多种腺病毒载体文库的多功能工具包。
Mol Ther Methods Clin Dev. 2024 Oct 18;32(4):101356. doi: 10.1016/j.omtm.2024.101356. eCollection 2024 Dec 12.
2
Clinical Application of Adenovirus (AdV): A Comprehensive Review.腺病毒(AdV)的临床应用:全面综述。
Viruses. 2024 Jul 8;16(7):1094. doi: 10.3390/v16071094.
3
Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells.

本文引用的文献

1
Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis.载脂蛋白 A-I 在兔颈动脉内皮中的表达可预防动脉粥样硬化。
Mol Ther. 2011 Oct;19(10):1833-41. doi: 10.1038/mt.2011.133. Epub 2011 Jul 19.
2
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs.靶向纠正患者特异性 iPSC 中与层粘连蛋白病相关的 LMNA 突变。
Cell Stem Cell. 2011 Jun 3;8(6):688-94. doi: 10.1016/j.stem.2011.04.019. Epub 2011 May 19.
3
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.
对人类气道上皮细胞中CFTR F508del进行有效功能校正的碱基编辑系统优化。
Nat Biomed Eng. 2025 Jan;9(1):7-21. doi: 10.1038/s41551-024-01233-3. Epub 2024 Jul 10.
4
Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines.不断演变的视野:腺病毒载体对癌症、基因治疗和疫苗的永恒影响。
Viruses. 2023 Dec 3;15(12):2378. doi: 10.3390/v15122378.
5
Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.CRISPR/Cas9 递送方法在干细胞治疗性基因编辑中的最新进展。
Stem Cell Rev Rep. 2023 Nov;19(8):2576-2596. doi: 10.1007/s12015-023-10585-3. Epub 2023 Sep 18.
6
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.基于腺病毒载体的COVID-19疫苗平台:现状
Vaccines (Basel). 2023 Feb 13;11(2):432. doi: 10.3390/vaccines11020432.
7
Gene Editing Technologies to Target HBV cccDNA.基因编辑技术靶向 HBV cccDNA。
Viruses. 2022 Nov 28;14(12):2654. doi: 10.3390/v14122654.
8
Advances in CRISPR Delivery Methods: Perspectives and Challenges.CRISPR 递送方法的进展:观点和挑战。
CRISPR J. 2022 Oct;5(5):660-676. doi: 10.1089/crispr.2022.0051.
9
Gene therapy approaches for equine osteoarthritis.马骨关节炎的基因治疗方法。
Front Vet Sci. 2022 Sep 28;9:962898. doi: 10.3389/fvets.2022.962898. eCollection 2022.
10
Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.用于基因治疗的病毒载体系统:进展与生物安全挑战的综合文献综述
Appl Biosaf. 2020 Mar 1;25(1):7-18. doi: 10.1177/1535676019899502.
NOD2 信号通路有助于先天免疫反应对抗辅助依赖性腺病毒载体,而不依赖于体内的 MyD88。
Hum Gene Ther. 2011 Sep;22(9):1071-82. doi: 10.1089/hum.2011.002. Epub 2011 Jul 8.
4
Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.生成一种逃避枯否细胞的腺病毒用于系统和肝脏靶向基因转移。
Mol Ther. 2011 Jul;19(7):1254-62. doi: 10.1038/mt.2011.71. Epub 2011 Apr 19.
5
Helper-dependent adenoviral vectors for liver-directed gene therapy.辅助依赖性腺病毒载体用于肝脏定向基因治疗。
Hum Mol Genet. 2011 Apr 15;20(R1):R7-13. doi: 10.1093/hmg/ddr143. Epub 2011 Apr 5.
6
Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.晚期鼠动脉粥样硬化病变的消退和稳定:LDL 降低和 HDL 升高基因转移策略的比较。
J Mol Med (Berl). 2011 Jun;89(6):555-67. doi: 10.1007/s00109-011-0722-x. Epub 2011 Jan 21.
7
Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells.腺病毒六邻体的修饰既可以实现肝细胞脱靶,也可以实现与库普弗细胞的潜在逃避靶向。
Mol Ther. 2011 Jan;19(1):83-92. doi: 10.1038/mt.2010.229. Epub 2010 Oct 19.
8
Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial cell-targeted gene therapy.辅助依赖性腺病毒载体在体外优于第一代载体,用于内皮细胞靶向基因治疗。
Mol Ther. 2010 Dec;18(12):2121-9. doi: 10.1038/mt.2010.176. Epub 2010 Aug 31.
9
Chromosomal integration of adenoviral vector DNA in vivo.腺病毒载体 DNA 在体内的染色体整合。
J Virol. 2010 Oct;84(19):9987-94. doi: 10.1128/JVI.00751-10. Epub 2010 Aug 4.
10
Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.血管活性肠肽增加了辅助依赖性腺病毒给药后的肝脏转导,并降低了固有免疫反应。
Mol Ther. 2010 Jul;18(7):1339-45. doi: 10.1038/mt.2010.84. Epub 2010 May 11.